feed,title,long_url,short_url
Benzinga,"BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish",https://benzinga.com/analyst-ratings/analyst-color/24/09/41033938/biomarin-stands-firm-on-2027-revenue-target-amid-ascendis-competition-goldman-sachs,https://da.gd/MIDFVs
